Moduretic tablets Keňa - angličtina - Pharmacy and Poisons Board

moduretic tablets

msd (pty) ltd 117 16th road, halfway house 1685, south africa - amiloride hcl and hydrochlorothiazide - tablet - 5 mg amiloride hcl and 50 mg hydrochlorothiazide - thiazides low-ceiling diuretics: plain thiazides

CAPOTEN captopril 5mg/mL oral liquid bottle Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

capoten captopril 5mg/ml oral liquid bottle

arrotex pharmaceuticals pty ltd - captopril, quantity: 5 mg/ml - oral liquid, solution - excipient ingredients: sodium benzoate; hydrochloric acid; sodium hydroxide; sodium citrate dihydrate; disodium edetate; purified water; citric acid - 1.hypertension: capoten (captopril) is indicated for the treatment of hypertension. in using capoten, consideration should be given to the risk of neutropenia/agranulocytosis (see precautions). capoten is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. the blood pressure lowering effects of captopril and thiazides are approximately additive. 2. myocardial infarction: capoten is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction less than or equal to 40%, and to reduce the incidence of overt heart failure and subsequent hospitalisations for congestive heart failure in these patients. the efficacy data for the use of captopril following myocardial infarction are strongest for initiation of therapy beyond 3 days post-infarct. 3. heart failure: capoten (captopril) is indicated for the treatment of heart failure. in symptomatic patients it is recommended that capoten be administered together with a diuretic. 4. diabetic nephropathy: capoten is indicated for the treatment of diabetic nephropathy in patients with type 1 insulin- dependent diabetes mellitus.

Cefepime Kabi Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

cefepime kabi

fresenius kabi new zealand limited - cefepime dihydrochloride monohydrate 1.1892 g equivalent to cefepime 1g - powder for injection - 1 g - active: cefepime dihydrochloride monohydrate 1.1892 g equivalent to cefepime 1g excipient: arginine - adults: cefepime kabi is indicated for the treatment of the indications listed below when caused by susceptible bacteria: · lower respiratory tract infections, including pneumonia and bronchitis · urinary tract infections , both complicated, including pyelonephritis, and uncomplicated infections · skin and skin structure infections · intra-abdominal infections, including peritonitis and biliary tract infections · septicaemia · empiric treatment in febrile neutropenic patients.

Cefepime Kabi Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

cefepime kabi

fresenius kabi new zealand limited - cefepime dihydrochloride monohydrate 2.3785 g equivalent to cefepime 2g - powder for injection - 2 g - active: cefepime dihydrochloride monohydrate 2.3785 g equivalent to cefepime 2g excipient: arginine - adults: cefepime kabi is indicated for the treatment of the indications listed below when caused by susceptible bacteria: · lower respiratory tract infections, including pneumonia and bronchitis · urinary tract infections , both complicated, including pyelonephritis, and uncomplicated infections · skin and skin structure infections · intra-abdominal infections, including peritonitis and biliary tract infections · septicaemia · empiric treatment in febrile neutropenic patients.